Conexeu Sciences, Inc. (CNXU)
3.10
-0.22
(-6.63%)
USD |
NASDAQ |
Oct 02, 16:00
3.14
+0.04
(+1.29%)
After-Hours: 20:00
Conexeu Sciences Net Income (Quarterly) : -7.726M for July 31, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -7.726M |
| April 30, 2026 | -2.304M |
| January 31, 2026 |
| Date | Value |
|---|---|
| October 31, 2025 | |
| April 30, 2025 | -0.458M |
| October 31, 2024 | -0.1091M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| AbbVie, Inc. | 3.604B |
| Vericel Corp. | 2.206M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Savara, Inc. | -40.23M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 7.726M |
| EPS Diluted (Quarterly) | -0.282 |
| Enterprise Value | 82.79M |
| Earnings Yield | -14.77% |